121 related articles for article (PubMed ID: 8818781)
21. Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients.
Geny B; Mettauer B; Muan B; Bischoff P; Epailly E; Piquard F; Eisenmann B; Haberey P
J Am Coll Cardiol; 1993 Oct; 22(4):1193-8. PubMed ID: 8409060
[TBL] [Abstract][Full Text] [Related]
22. Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans.
Ten Cate FJ; Widimsky P; Cornel JH; Waldstein DJ; Serruys PW; Waaler A
Circulation; 1993 Nov; 88(5 Pt 1):2123-7. PubMed ID: 8222106
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of left ventricular cavity opacification by harmonic imaging after venous injection of Albunex.
Lindner JR; Dent JM; Moos SP; Jayaweera AR; Kaul S
Am J Cardiol; 1997 Jun; 79(12):1657-62. PubMed ID: 9202358
[TBL] [Abstract][Full Text] [Related]
24. On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion.
Bleeker H; Shung K; Barnhart J
J Ultrasound Med; 1990 Aug; 9(8):461-71. PubMed ID: 2204718
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a relation between inspired gas mixture and the left ventricular contrast achieved with Albunex in a canine model.
Geiser EA; Buss DD; Wible JH; Cunningham MS; Webb AI; Wilson DC; Yang M
Clin Cardiol; 1996 Apr; 19(4):289-95. PubMed ID: 8706368
[TBL] [Abstract][Full Text] [Related]
26. Relation of contrast echo intensity and flow velocity to the amplification of contrast opacification produced by intermittent ultrasound transmission.
Ohmori K; Cotter B; Kwan OL; Mizushige K; DeMaria AN
Am Heart J; 1997 Dec; 134(6):1066-74. PubMed ID: 9424067
[TBL] [Abstract][Full Text] [Related]
27. Increasing the dose and rate of Albunex infusion leads to superior left ventricular contrast effect.
Dolan MS; Dent J; deFilippi C; Christopher T; Wible JH; Labovitz AJ
J Am Soc Echocardiogr; 1998 May; 11(5):426-32. PubMed ID: 9619613
[TBL] [Abstract][Full Text] [Related]
28. Pulsatile pressure affects the disappearance of echocardiographic contrast agents.
Padial LR; Chen MH; Vuille C; Guerrero JL; Weyman AE; Picard MH
J Am Soc Echocardiogr; 1995; 8(3):285-92. PubMed ID: 7640022
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the efficacy of two air-based contrast agents in dogs.
Uchimoto R; Niwa K; Tsuda N; Miyazawa T; Bräutigam M
Eur J Ultrasound; 2000 May; 11(2):127-33. PubMed ID: 10781661
[TBL] [Abstract][Full Text] [Related]
30. Effect of static pressure on acoustic transmittance of Albunex microbubble suspensions.
Brayman AA; Azadniv M; Miller MW; Meltzer RS
J Acoust Soc Am; 1996 Apr; 99(4 Pt 1):2403-8. PubMed ID: 8730086
[TBL] [Abstract][Full Text] [Related]
31. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres.
Sanders WE; Cheirif J; Desir R; Zoghbi WA; Hoyt BD; Schulz PE; Quiñones MA
Am Heart J; 1991 Dec; 122(6):1660-5. PubMed ID: 1957761
[TBL] [Abstract][Full Text] [Related]
32. Broadband measurements of phase velocity in Albunex suspensions.
Mobley J; Marsh JN; Hall CS; Hughes MS; Brandenburger GH; Miller JG
J Acoust Soc Am; 1998 Apr; 103(4):2145-53. PubMed ID: 9566335
[TBL] [Abstract][Full Text] [Related]
33. Ultrasound scattering properties of Albunex microspheres.
de Jong N; Hoff L
Ultrasonics; 1993; 31(3):175-81. PubMed ID: 8484195
[TBL] [Abstract][Full Text] [Related]
34. Thresholds for inertial cavitation in albunex suspensions under pulsed ultrasound conditions.
Chang PP; Chen WS; Mourad PD; Poliachik SL; Crum LA
IEEE Trans Ultrason Ferroelectr Freq Control; 2001 Jan; 48(1):161-70. PubMed ID: 11367783
[TBL] [Abstract][Full Text] [Related]
35. [Assessment of left ventricular volume by contrast echocardiography].
Iwamori K; Ishikawa K
Nihon Rinsho; 1998 Apr; 56(4):926-9. PubMed ID: 9577610
[TBL] [Abstract][Full Text] [Related]
36. Quantitative measurements of second harmonic Doppler using ultrasound contrast agents.
Chang PH; Shung KK; Levene HB
Ultrasound Med Biol; 1996; 22(9):1205-14. PubMed ID: 9123645
[TBL] [Abstract][Full Text] [Related]
37. Inhaled gases affect the ultrasound contrast produced by Albunex in anesthetized dogs.
Wible JH; Wojdyla JK; Bales GL; McMullen WN; Geiser EA; Buss DD
J Am Soc Echocardiogr; 1996; 9(4):442-51. PubMed ID: 8827627
[TBL] [Abstract][Full Text] [Related]
38. The influence of Albunex on the pulmonary circulation in patients with pulmonary hypertension or left heart failure.
Zotz RJ; Genth S; Mitrovic V; Waaler A; Erbel R; Meyer J
Eur Heart J; 1996 Feb; 17(2):302-7. PubMed ID: 8732386
[TBL] [Abstract][Full Text] [Related]
39. [Ultrasound scattering properties of Albunex microspheres].
Takamoto T; Shiina T
Nihon Rinsho; 1998 Apr; 56(4):871-5. PubMed ID: 9577600
[TBL] [Abstract][Full Text] [Related]
40. Experimental study of stability of a contrast agent in an ultrasound field.
Wu J; Tong J
Ultrasound Med Biol; 1998 Feb; 24(2):257-65. PubMed ID: 9550184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
